Concepedia

Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib

Anuj Patel, Mei Sheng Duh, Victoria Barghout, Mihran Yenikomshian, Yongling Xiao, Willy Wynant, Majid Tabesh, Charles S. Fuchs

Clinical Colorectal Cancer · 2018 · 25 citations · 17 references

Concepts

MedicineOncologyPharmacotherapyGastrointestinal OncologyOncology PharmacotherapySurvival AnalysisCancer RegistriesCancer Survival AnalysisColorectal CancerMetastatic Cancer ManagementMetastatic Disease ManagementMetastatic Disease TreatmentCancer Registry Data AnalysisColorectal Cancer EpidemiologyHazard Ratio ModelingMedication Possession RatioMedication Possession Ratio AnalysisObservational Data CollectionSide Effect Profile

References

17

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Colorectal cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Stacey A. Fedewa et al. · CA A Cancer Journal for Clinicians · 2017 · 3.9K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Axel Grothey, Eric Van Cutsem, Alberto Sobrero et al. · The Lancet · 2012 · 2.9K citations

Medicine, Oncology, Pharmacology +10

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

Medicine, Oncology, Chemotherapy +14